Bessemer Group Inc Xencor Inc Transaction History
Bessemer Group Inc
- $61.3 Billion
- Q4 2024
A detailed history of Bessemer Group Inc transactions in Xencor Inc stock. As of the latest transaction made, Bessemer Group Inc holds 130 shares of XNCR stock, worth $1,748. This represents 0.0% of its overall portfolio holdings.
Number of Shares
130
Previous 130
-0.0%
Holding current value
$1,748
Previous $3,000
-0.0%
% of portfolio
0.0%
Previous 0.0%
Shares
3 transactions
Others Institutions Holding XNCR
# of Institutions
199Shares Held
73.7MCall Options Held
1.7KPut Options Held
4.2K-
Black Rock Inc. New York, NY11.1MShares$149 Million0.0% of portfolio
-
Primecap Management CO Pasadena, CA8.98MShares$121 Million0.16% of portfolio
-
Vanguard Group Inc Valley Forge, PA8.02MShares$108 Million0.0% of portfolio
-
Eco R1 Capital, LLC San Francisco, CA6.14MShares$82.6 Million6.6% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD4.04MShares$54.3 Million0.01% of portfolio
About Xencor Inc
- Ticker XNCR
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 59,698,100
- Market Cap $803M
- Description
- Xencor, Inc., a clinical stage biopharmaceutical company, focuses on the discovery and development of engineered monoclonal antibody and cytokine therapeutics to treat patients with cancer and autoimmune diseases. The company provides Sotrovimab that targets the SARS-CoV-2 virus; Ultomiris for the treatment of patients with paroxysmal nocturnal ...